Rights and permissions
About this article
Cite this article
No advantage for autologous BMT in relapsed childhood ALL. Inpharma Wkly. 1007, 12 (1995). https://doi.org/10.2165/00128413-199510070-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199510070-00030